The all-in-one platform to find and track your stocks and investments
Discover the features
Statistics
Market Cap
371 billion
PE Ratio
25.12 x
Beta (volatility)
0.52
Earnings Per Share
6.13
About
ISIN : US4781601046
It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices.
The Consumer Health segment offers...
Price
Performance Comparison
| Johnson & Johnson | |
|---|---|
| 1 year return |
+6 %
|
| 5 years return |
+31 %
|
Valuation
| Price to Book | Payout ratio | PEG Ratio |
|---|---|---|
| 5.28 | 48 % | 0.92 |
| Price to Sales | Price / FCF | E.V.R. |
|---|---|---|
| 4.35 | 20.51 | 4.40 |
Price–Earnings Ratio History
For this company, we show you a quick help in graphical form that tells you if the stock looks overvalued, undervalued or fairly priced, and by how much. Stop paying too much for your shares.
Unlock valuation chart for this company
Dividend History
Uninter. Dividend
23 years
Frequency
4x / year
Dividends in 2023
March, June, September, December
Dividends in 2022
March, June, September, December
March, June, September, December
Dividends in 2022
March, June, September, December
Forward Annual Amount
$4.96
Ex-dividend
11/26/2024
Number of Outstanding Shares
Sales segmentation
Financials
Year-over-Year growth
Profitability
Health
News
Starboard Value Buys Into Dow Jones Spinoff; ELF Beauty Rallies
10/21/2024
The 'Texas two-step' is back as J&J tries to shed talc lawsuits for a third time
10/20/2024
All It Takes Is $2,500 Invested in Each of These 3 High-Yield Dow Dividend Stocks to Help Generate Over $300 in Passive Income Per Year
10/19/2024
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
10/19/2024
Johnson & Johnson (JNJ): Growth Prospects Enhanced by Key Acquisitions and Approvals
10/18/2024
Pharma Stock Roundup: JNJ's Q3 Earnings, FDA Nod to Some New Drugs
10/18/2024
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
10/18/2024
Boston Scientific stock down as Needham cuts to Hold on growth concerns
10/18/2024
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
10/18/2024
Manning & Napier's Strategic Bet on TransUnion Amplifies Portfolio Impact
10/17/2024
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike
10/17/2024
Does Johnson & Johnson (NYSE:JNJ) Have A Healthy Balance Sheet?
10/17/2024
Create a portfolio & add this stock
Add this stock and others to your own virtual portfolio and get personalised information : total annual dividends & total value, sectors breakdown, etc.
Privacy Policy • Terms and Conditions
© Copyright 2020-2024 Epsylia OÜ - All rights reserved
Moning is a platform that does not manage any funds and is purely educational. We do not provide any investment advice.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.